For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug-coated balloon from Medtronic Inc. provided a consistently favorable treatment effect in patients with diabetes in a landmark study of the investigational medical device, which is under review for FDA approval. 


Merit Medical Systems Inc. settled a dispute regarding the distribution of the SecureLoc Safety Introducer Needle with Bard Access Systems. Under the terms of a settlement agreement, Bard Access Systems granted Merit a non-exclusive, worldwide license to manufacture and distribute the SecureLoc Safety Introducer Needle under its own trademark.

Lantheus Medical Imaging Inc. and Shine Medical Technologies Inc. announced that the companies have entered into a strategic agreement for the future supply of molybdenum-99 (Mo-99). The supply agreement marks Lantheus’ first with a prospective United States supplier of Mo-99.

Solid Water HE is the next generation of solid water phantoms by Gammex. It is designed for both therapy and imaging with improved uniformity and durability in mind.

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, implanted the Solo Smart surgical replacement performed by David Heimansohn, M.D., at St. Vincent’s Heart Hospital in Indianapolis, Ind.

This multi-center pilot study focused on gathering data supporting the safety and performance of the Tack Endovascular System in 35 subjects with Critical Limb Ischemia (CLI) due to vascular disease below the knee. 

Cardinal Health announced that its MynxGrip Vascular Closure Device recently received U.S. Food and Drug Administration (FDA) approval for use to close femoral veins. The MynxGrip device is now indicated for use to seal 5F, 6F and 7F femoral arterial and femoral venous access sites.

Cardiovascular Systems Inc. received the CE Mark for its Stealth 360º Orbital Atherectomy System (OAS). Stealth 360º is a percutaneous OAS that is indicated to treat patients who suffer from peripheral arterial disease (PAD).

Subscribe Now